StonvexLoading…
StonvexStonvexStonvexCore line items from FCEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-10-31 | Annual 2024 2024-10-31 | Annual 2023 2023-10-31 | Annual 2022 2022-10-31 |
|---|---|---|---|---|
Revenue | $158.16M | $112.13M | $123.39M | $130.48M |
Operating Income | $-192.35M | $-158.49M | $-136.08M | $-143.72M |
Net Income | $-187.90M | $-126.01M | $-107.57M | $-142.72M |
EPS (Diluted) | $-7.42 | $-7.83 | $-7.92 | $-11.43 |
Total Assets | $932.15M | $944.12M | $955.52M | $939.72M |
Total Liabilities | $201.00M | $216.66M | $195.22M | $185.33M |
Cash & Equivalents | $278.10M | $148.13M | $249.95M | $458.06M |
Free Cash Flow OCF − CapEx | $-143.89M | $-200.63M | $-179.60M | $-133.25M |
Shares Outstanding | 46.08M | 20.38M | 15.02M | 405.56M |